Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Fintel reports that on November 11, 2025, Wells Fargo maintained coverage of Keros Therapeutics (NasdaqGM:KROS) with a ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Keros Therapeutics, Inc. ( NASDAQ:KROS ) defied analyst predictions to release its quarterly results, which were ...

Fintel reports that on November 6, 2025, Wedbush maintained coverage of Keros Therapeutics (NasdaqGM:KROS) with a Neutral ...

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

John Arcilla and Rochelle Pangilinan finally made their much-anticipated appearance as Hagorn and Agane on "Encantadia ...

An eclectic, high-end sale known as “Connoisseur’s Delight,” the event is led by a highly important Early Cycladic II Spedos Type marble idol of the ancient Greek Keros-Syros Culture, circa 1700-2300 ...

When raising capital in the U.S., owners and directors of foreign companies have to be cognizant of how restructuring can be used by creditors ...

Keros, a clinical-stage biopharmaceutical company focused on developing therapeutics for disorders linked to transforming growth factor-beta protein signaling, stated it continues to target a first ...